Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine

ConclusionsAltogether, these results identify PS and PD as novel ICD inducers that could be effectively combined with PDT in cancer therapy.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research

Related Links:

This study has suggested that the β-CD-GO could play an efficient and beneficial source of the adsorbent for the purpose of eliminating Cd(II) from aqueous solution.Graphical abstract
Source: Process Biochemistry - Category: Biochemistry Source Type: research
Publication date: April 2020Source: Biochemical Systematics and Ecology, Volume 89Author(s): Diego L. Lucca, Giovanna P. Sá, Leonardo R. Polastri, Denise M.B. Ghiraldi, Nagela P. Ferreira, Lucas U.R. Chiavelli, Ana L.T.G. Ruiz, Francielle P. Garcia, Jessica C. Paula, Celso V. Nakamura, Tania U. Nakamura, Brenda Kischkel, Debora B. Scariot, Dyenefer P. Fonseca, Silvana M.O. Santin, Maria A.M. Gutierre, Melyssa F.N. Negri, Armando M. PominiAbstractOrchidaceae are one of the largest families of flowering plants. In this work, the first phytochemical study of the non-flowering parts of the South American species Stanhop...
Source: Biochemical Systematics and Ecology - Category: Biochemistry Source Type: research
This article is protected by copyright. All rights reserved
Source: Biotechnology and Applied Biochemistry - Category: Biochemistry Authors: Tags: Original Article Source Type: research
Publication date: Available online 15 February 2020Source: Thermochimica ActaAuthor(s): G. Dugast, A. Settar, K. Chetehouna, N. Gascoin, J.-L. Marceau, M. Bouchez, M. De BatsAbstractSilicone-based composites material as Thermal Protection System (TPS) found a large use in the aerospace industry to protect wall structures from severe heating (airframe or propulsion parts, including ramjet type). The matrix of the composite material is often reinforced with fillers, such as Carbon Fibres (CFs) and Silicon Carbide Powder (SCP). This formulation aims to improve the thermomechanical properties which leads to significant impact ...
Source: Thermochimica Acta - Category: Chemistry Source Type: research
Abstract The neurotrophin receptor tyrosine kinase (NTRK1-3) genes have been identified as key fusion partners in a range of pediatric cancers. In childhood cancers, ETV6-NTRK3 fusions are found in the majority of infantile fibrosarcomas and congenital mesoblastic nephromas. NTRK fusions are also found in mammary analog secretory carcinomas (MASC), secretory breast carcinomas, and with modest frequency in high-grade gliomas in very young children. While there are a range of multi-receptor tyrosine kinase inhibitors that show efficacy against TRK kinases, there are now multiple highly selective TRK inhibitors in cl...
Source: Paediatric Drugs - Category: Pediatrics Authors: Tags: Paediatr Drugs Source Type: research
AbstractThe neurotrophin receptor tyrosine kinase (NTRK1-3) genes have been identified as key fusion partners in a range of pediatric cancers. In childhood cancers,ETV6-NTRK3 fusions are found in the majority of infantile fibrosarcomas and congenital mesoblastic nephromas.NTRK fusions are also found in mammary analog secretory carcinomas (MASC), secretory breast carcinomas, and with modest frequency in high-grade gliomas in very young children. While there are a range of multi-receptor tyrosine kinase inhibitors that show efficacy against TRK kinases, there are now multiple highly selective TRK inhibitors in clinical evalu...
Source: Pediatric Drugs - Category: Pediatrics Source Type: research
ConclusionsAYA in the US experience disparities in cancer survival based on insurance status, independent of late stage of presentation. Patients age 26 ‐39 may be especially vulnerable to health outcomes associated with poor socioeconomic status, treatment disparities, and poor access to care.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Tags: ORIGINAL RESEARCH Source Type: research
Cancers, Vol. 9, Pages 103: Secondary Intracranial Tumors Following Radiotherapy for Pituitary Adenomas: A Systematic Review Cancers doi: 10.3390/cancers9080103 Authors: Ryuya Yamanaka Eisuke Abe Toshiteru Sato Azusa Hayano Yasuo Takashima Pituitary adenomas are often treated with radiotherapy for the management of tumor progression or recurrence. Despite the improvement in cure rates, patients treated by radiotherapy are at risk of development of secondary malignancies. We conducted a comprehensive literature review of the secondary intracranial tumors that occurred following radiotherapy to pituitary aden...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research
This study was supported by grant from National Natural Science Foundation (81472184) of China.}Citation Format: Chengkun Wang, Xiaorong Liu, Qinwei Qiu, Zhijie Zhang, Jiang Yin, Guopei Zheng, Zhimin He. TCRP1 gene promotes NIH/3T3 cell transformation by over-activating PDPK1 and Akt. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2719. doi:10.1158/1538-7445.AM2015-2719
Source: Cancer Research - Category: Cancer & Oncology Authors: Tags: Carcinogenesis Source Type: research
Tumor-associated proteases (TAPs) have been intensively studied because of their critical roles in cancer development. As a case in point, expression of matrix metalloproteases (MMP) is significantly up-regulated in tumorigenesis, invasion, and metastasis among a majority of cancers. Here we present a prodrug-type, MMP-2-responsive nanoprobe system with high efficiency and low toxicity for detecting MMP-2-overexpressed tumors. The nanoprobe system is featured by its self-assembled fabrication and FRET effect. This prodrug-type nanoprobe is selectively activated by MMP-2, and thus useful for detection of the MMP-2-overexpre...
Source: Theranostics - Category: Molecular Biology Authors: Tags: Research Paper Source Type: research
More News: Brain Tumor | Cancer | Cancer & Oncology | Cancer Therapy | Cancer Vaccines | Fibrosarcoma | Glioma | Immunotherapy | PET Scan | Vaccines